Update date
31 Jan 2026
Shareable Research Card
This metric view shows DOO - BRP Inc. research and development expense history from SEC company facts.
Use it to verify the latest reported value, compare nearby periods, and jump to a cross-company ranking when a curated insight exists.
Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Values may differ by reporting period and company taxonomy.
Return Loop
This metric history becomes more useful after the next quarterly or annual filing because the latest reported value, period, and company comparison context can all change.
Metric freshness comes from the latest SEC company fact available for this taxonomy tag and the paired company facts page.
Latest update
Latest reported research and development expense: CA$434,700,000. Open the source-backed page to compare this metric with the newest filing-backed context.
Update date
31 Jan 2026
Page type
Metric history
Latest period
2025
SEC-backed company facts were refreshed from filings filed on 26 Mar 2026.
Benchmark Context
BRP Inc. sits in the top quarter of the current research and development expense sample.
Compared with
Compared with 44 companies reporting research and development expense in CAD. This keeps the comparison on the same metric and unit family.
Why this is notable
That is about 144.9x the current visible midpoint. Research And Development Expense is up about 11% versus the comparable prior period.
Peer comparisons use the same metric and compatible units only. Latest reported periods may differ across companies, so open each company page before drawing conclusions.
Save this filer page
Create a free account to keep this page in your watchlists. After verification, we will save it automatically and open your saved research list.
Financial Metric Page
Latest period: 2025. Period end: 31 Jan 2026. Units: CAD. Frequency: annual.
Research And Development Expense is an SEC-reported metric from company XBRL facts.
Source: SEC Company Facts
Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Reporting periods may differ by company.
Direct filing link is shown only when a matched SEC filing document is available for this metric context.
Compare latest available Research And Development Expense levels across SEC-reporting companies, then open each company metric page for SEC-backed verification. Reporting periods may differ by company.
BRP Inc. appears at rank #1 in the latest comparison sample.
| Rank | Company | Latest value | Reported period | Next step |
|---|---|---|---|---|
| 1 | BRP Inc. (doo) | CA$434,700,000 | Year - 31 Jan 2026 | Open BRP Inc. Research And Development Expense |
| 2 | CAE INC (cae) | CA$123,200,000 | Year - 31 Mar 2025 | Open CAE INC Research And Development Expense |
| 3 | BCE INC (bce) | CA$60,000,000 | Year - 31 Dec 2025 | Open BCE INC Research And Development Expense |
| 4 | CYBIN INC. (help) | CA$54,910,000 | Year - 31 Mar 2025 | Open CYBIN INC. Research And Development Expense |
| 5 | CAMECO CORP (ccj) | CA$38,467,000 | Year - 31 Dec 2025 | Open CAMECO CORP Research And Development Expense |
| 6 | Grace Therapeutics, Inc. (grce) | CA$38,366,000 | Year - 31 Mar 2019 | Open Grace Therapeutics, Inc. Research And Development Expense |
Compare periods with the same frequency first, then use YoY and TTM series to confirm whether changes are structural or one-off.
| Period | Value | YoY Chg | Change % | Start Date | End Date | Report | Filed | Fiscal Year | Fiscal Period |
|---|---|---|---|---|---|---|---|---|---|
| 2025 | CA$434,700,000 | +CA$43,600,000 | +11% | 01 Feb 2025 | 31 Jan 2026 | 40-F | 26 Mar 2026 | 2026 | FY |
| 2024 | CA$391,100,000 | -CA$10,800,000 | -2.7% | 01 Feb 2024 | 31 Jan 2025 | 40-F | 26 Mar 2026 | 2026 | FY |
| 2023 | CA$401,900,000 | +CA$34,200,000 | +9.3% | 01 Feb 2023 | 31 Jan 2024 | 40-F | 26 Mar 2025 | 2025 | FY |
| 2022 | CA$367,700,000 | +CA$77,900,000 | +27% | 01 Feb 2022 | 31 Jan 2023 | 40-F | 28 Mar 2024 | 2024 | FY |
| 2021 | CA$289,800,000 | +CA$47,500,000 | +20% | 01 Feb 2021 | 31 Jan 2022 | 40-F | 23 Mar 2023 | 2023 | FY |
| 2020 | CA$242,300,000 | +CA$3,900,000 | +1.6% | 01 Feb 2020 | 31 Jan 2021 | 40-F | 25 Mar 2022 | 2022 | FY |
| 2019 | CA$238,400,000 | +CA$16,700,000 | +7.5% | 01 Feb 2019 | 31 Jan 2020 | 40-F | 25 Mar 2021 | 2021 | FY |
| 2018 | CA$221,700,000 | +CA$23,100,000 | +12% | 01 Feb 2018 | 31 Jan 2019 | 40-F | 09 Apr 2020 | 2020 | FY |
| 2017 | CA$198,600,000 | 02 Feb 2017 | 31 Jan 2018 | 40-F | 22 Mar 2019 | 2019 | FY |